Keywords: EU Biodiversity Strategy; CICES; Indicators; MAES; Natural Capital;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Cascade model; CICES; Decision-making; Ecosystem services; Environmental management; Environmental policy; Monitoring; MAES; Valuation;
Keywords: Chromatography-mass spectrometry; Emerging organic pollutant; Environmental analysis; Flame retardant; Microwave-assisted extraction; Personal-care product; Pharmaceutical; Plasticizer; Sample preparation; Surfactant; ADBI; 4-Acetyl-1,1-dimethyl-6-tert-bu
Where concepts meet the real world: A systematic review of ecosystem service indicators and their classification using CICES
Keywords: Ecosystem service classification; Ecosystem service mapping; Ecosystem service assessment; Concept matching; MAES; CICES;
Requirements for the selection of ecosystem service indicators - The case of MAES indicators
Keywords: Ecosystem service; Policy relevance; Validity; Indicator; Valuation; MAES;
National ecosystem services mapping at multiple scales â¿¿ The German exemplar
Keywords: Ecosystem services; Mapping; Indicators; TEEB; MAES; Hotspots; Scales;
Immunogenicity and safety of AS03A-adjuvanted H5N1 influenza vaccine prepared from bulk antigen after stockpiling for 4 years
Keywords: AEs; adverse events; CBER; US Center for Biologics Evaluation and Research; CHMP; Committee for Medicinal Products for Human Use; CIs; confidence intervals; GMTs; geometric mean titers; HA; hemagglutinin antigen; HI; hemagglutination-inhibition; MAEs; med
Immunogenicity and safety of an AS03-adjuvanted H5N1 pandemic influenza vaccine in Korean adults: A phase IV, randomized, open-label, controlled study
Keywords: AS03; H5N1 vaccine; Pandemic influenza; Korean adults; AEs; adverse events; CBER; US Center for Biologics Evaluation and Research; CHMP; Committee for Medicinal Products for Human Use; CI; confidence interval; EMA; European Medicines Agency; FDA; US Food
An observer-blind, randomized, multi-center trial assessing long-term safety and immunogenicity of AS03-adjuvanted or unadjuvanted H1N1/2009 influenza vaccines in children 10-17 years of age
Keywords: AEs; adverse events; CBER; Center for Biologics Evaluation & Research; CHMP; Committee for Medicinal Products for Human Use; CI; confidence interval; GMFR; geometric mean fold rise; GMT; geometric mean titer; HA; hemagglutinin; HI; hemagglutination inhibi
Pregnancy and safety outcomes in women vaccinated with an AS03-adjuvanted split virion H1N1 (2009) pandemic influenza vaccine during pregnancy: A prospective cohort study
Keywords: AEs; adverse events; AESI; adverse events of special interest; AS03; oil-in-water emulsion-based Adjuvant System AS03; CDC; Centers for Disease Control and Prevention; CHMP; Committee for Medicinal Products for Human Use; EGA; estimated gestational age; G
Current Myocardial Infarction Classification Does Not Predict Risks of Early Revascularization
Keywords: ACC; aortic cross-clamp; CABG; coronary artery bypass grafting; CCS; Canadian Cardiovascular Society; CHF; congestive heart failure; CI; confidence interval; COPD; chronic obstructive pulmonary disease; CPB; cardiopulmonary bypass; IABP; intraaortic ballo